Microstructure Imaging in Stroke Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDanish Research Centre for Magnetic Resonance
About this trial
The purpose of this study is to establish a methodological framework based on existing advanced neuroimaging technologies as a new clinical neuroimaging tool for assessment of possible affected brain connections in stroke and TIA patients. Thus, providing new insights into microstructural changes that may underline why those patients experience deficits like fatigue.
Eligibility criteria
Qualifiers
Stroke or TIA (ABCD2>4 and/or acute Diffusion-Weighted Image (DWI) lesion).
Modified Rankin Scale <=2.
As perceived by the investigator, have the ability to comply with all requirements of the study protocol.
Have the ability to understand and sign the Informed Consents Form.
Disqualifiers
The DRCMR´s general exclusion criteria for MRI research.
Pregnancy or lactation; human chorionic gonadotropin (hCG) urine test is offered for women < 55 years.
Major medical illness (for instance: anemia, diabetes mellitus, thyroid disorders, cardiovascular disease, electrolyte imbalance, etc.)
Treated with ritalin or modafinil.
Trial design
Treatments tested in this trial
- Clinical Assessment
- MRI scan
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Danish Research Centre for Magnetic Resonance
Lead sponsor
Bispebjerg Hospital
Collaborator
Source ClinicalTrials.gov